Stock Code: 300677
Stock Abbreviation: Yingke Medical
Announcement Number: 2026-040
Yingke Medical Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On April 23, 2026, and May 18, 2026, the Company convened the 14th (regular) meeting of the 4th Board of Directors and the 2025 Annual General Meeting of Shareholders, respectively, to review and approve the proposal regarding the Company's and its subsidiaries' applications for credit limits and guarantees from banks.
To meet the operational needs of the Company and its subsidiaries, the Company and its subsidiaries plan to apply for a total credit limit (hereinafter referred to as "Credit Limit") not exceeding RMB 29.95 billion from banks and other financial institutions, with a total guarantee amount not exceeding RMB 29.95 billion. The authorization period is from the date of approval by the Company's 2025 Annual General Meeting of Shareholders until the next Annual General Meeting of Shareholders. For specific details, please refer to the announcements published on the Giant Tide Information Network (www.cninfo.com.cn) regarding the Company's and its subsidiaries' applications for credit limits and guarantees and the resolutions of the 2025 Annual General Meeting of Shareholders (Announcement Numbers: 2026-023, 2026-036).
1. Overview of Guarantee Matters
Jiangxi Yingke Medical Co., Ltd. (hereinafter referred to as "Jiangxi Yingke") has applied for a credit limit from Xiamen International Bank Co., Ltd. Shanghai Branch (hereinafter referred to as "Xiamen International Bank Shanghai Branch") due to operational needs. The Company provides a joint liability guarantee of RMB 100 million for the above credit and has recently signed a "Guarantee Contract" (hereinafter referred to as "Guarantee Contract One") with Xiamen International Bank Shanghai Branch.
Shanghai Yingen International Trade Co., Ltd. (hereinafter referred to as "Shanghai Yingen") has applied for a credit limit from Xiamen International Bank Shanghai Branch due to operational needs. The Company provides a joint liability guarantee of RMB 20 million for the above credit and has recently signed a "Guarantee Contract" (hereinafter referred to as "Guarantee Contract Two") with Xiamen International Bank Shanghai Branch.
Shandong Yingke Medical Products Co., Ltd. (hereinafter referred to as "Shandong Yingke") has applied for a credit limit from China Merchants Bank Co., Ltd. Weifang Branch (hereinafter referred to as "China Merchants Bank Weifang Branch") due to operational needs. The Company provides a joint liability guarantee of RMB 100 million for the above credit and has recently signed an "Irrevocable Maximum Guarantee Letter" (hereinafter referred to as "Guarantee Contract Three") with China Merchants Bank Weifang Branch.
Anqing Yingke Medical Co., Ltd. (hereinafter referred to as "Anqing Yingke") and Yingke Medical International (Hong Kong) Co., Ltd. (hereinafter referred to as "Yingke International") have jointly applied for a credit limit from China Trust Commercial Bank Co., Ltd. Shanghai Branch (hereinafter referred to as "China Trust Commercial Bank Shanghai Branch") due to operational needs. The Company provides a joint liability guarantee of USD 30 million for the above credit and has recently signed a "Maximum Guarantee Contract" (hereinafter referred to as "Guarantee Contract Four") with China Trust Commercial Bank Shanghai Branch.
The progress of this guarantee is as follows: